376900.KQ ROKIT Healthcare Inc.
- Market cap
- KRW 266B
- P/E
- -
- P/B
- 39.30x
- ROE
- -330.1%
- Dividend yield
- -
- Fundamental score
- 1.1/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 376900.KQ undervalued?
Graham numberThe Graham number of ROKIT Healthcare Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ROKIT Healthcare Inc. fundamental analysis
4 of 21 checks passedROE 0/2
Low return on equity (-330.1%), below 10%.
ROA 0/1
Return on assets (-20.7%) is below the industry median (2.5%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (80.6%) is above the industry median (28.6%).
Revenue Growth 2/2
Revenue grew 42.1% a year over the past 3 years.
Short-term Liquidity 0/1
Current assets do not cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (0.4%), 40% or less.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Cash Runway 0/2
Cash covers 0.7 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (39.3x) is above the industry median (5.0x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
ROKIT Healthcare Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ROKIT Healthcare Inc.
ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult st…
Full company profileROKIT Healthcare Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
ROKIT Healthcare Inc. annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 9.15B | 12.4B | 13.1B | 26.2B | 32.5B |
| Gross Profit | 3.10B | 4.05B | 5.98B | 15.7B | 12.9B |
| Operating Income | -13.9B | -7.36B | -5.57B | 453M | -31.3B |
| EBITDA | 7.91B | 24.3B | 496M | 3.45B | -15.1B |
| Net Income | 1.87B | 16.6B | -7.65B | -2.85B | -22.3B |
| EPS | 234 | 2,070 | -954 | -185 | -1,424 |
| Balance Sheet | |||||
| Total Assets | 14.2B | 8.48B | 11.3B | 55.0B | 108B |
| Total Liabilities | 112B | 86.9B | 88.4B | 43.5B | 101B |
| Shareholders' Equity | -97.5B | -78.5B | -77.1B | 11.6B | 6.77B |
| Cash & Short-term Investments | 3.56B | 965M | 3.01B | 31.1B | 20.2B |
| Cash Flow | |||||
| Operating Cash Flow | -6.59B | -3.92B | -5.00B | -17.2B | -29.5B |
| Capital Expenditure | 217M | 296M | 196M | 536M | 1.30B |
| Free Cash Flow | -6.80B | -4.21B | -5.20B | -17.8B | -30.8B |
| Ratios | |||||
| ROE | - | - | - | -24.6% | -330.1% |
| ROA | 13.2% | 195.8% | -67.5% | -5.2% | -20.7% |
| Net Profit Margin | 20.5% | 133.7% | -58.3% | -10.8% | -68.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
ROKIT Healthcare Inc. dividends
ROKIT Healthcare Inc. has not paid dividends in the last 4 fiscal years.
Who owns ROKIT Healthcare Inc.
- Insiders 24.05%
- Institutions 3.93%
- Public & others 72.02%
- Shares outstanding 15.8M
- Free float 12.2M
ROKIT Healthcare Inc. company profile
- Company name
- ROKIT Healthcare Inc.
- Ticker
- 376900.KQ
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Employees
- 89
- Fiscal year end
- December
- Address
- Digital-ro 10-gil 9, Seoul, South Korea, 08514
- Phone
- 82 1 899 7296
- Website
- rokithealthcare.com
About ROKIT Healthcare Inc.
ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media; HumaTein, a human cell-derived whole extracellular matrix; EpiTem, a reconstructed human epidermis model; and anti-aging supplements, as well as operates a tissue bank. The company was formerly known as ROKIT Inc. and changed its name to ROKIT Healthcare Inc. in 2018. The company was incorporated in 2012 and is based in Seoul, South Korea.
ROKIT Healthcare Inc. management
3- Mr. Seok-hwan YooChairman & CEO · born 1957
- Yong-gyu LeeVP & CFO · born 1971
- SangMin LeeExecutive Director · born 1971